CHEMISTR Y OF AN T IHYPE R T E N S I VE A G EN T S Presentation by Abhishek Ghara I M. Pharm Dept. Pharmaceutical Chemistry
Hy p er t ens i on Also known as h i gh b l o o d p r e s su r e . It i s a diso r der t o whic h b o th e n vi r o nmenta l and gen e tic f ac t o rs contribu t e. Structural narrowing of arteries.
C l ass i f i ca t i o n o f B l o o d P ress u re Ca t e g o ry S y st e m i c B P ( m m H g ) D i a s t o li c B P (mm Hg ) No rm a l < 1 20 < 8 H y p e rt e n s i o n S t a g e 1 14 - 15 9 9 - 9 9 S t a g e 2 16 - 16 9 1 - 1 9 S t a g e 3 18 - 20 9 1 1 - 1 1 9 S t a g e 4 >2 1 > 1 2
Classification of antihypertensive drug 1) Sympat h o ly t ic drugs Centrally acting antia d renergic agents. A drenergi c neu r o n blo c king agents. A lph a adrenergi c blo c k e r s. B e t a adrenergi c blo c k e r s. Alpha-b e ta adrenergi c blo c k e r s. 2) V asodi la t o r s Nitric o xide release r s. P ota s sium c h annel opene r s. C a lcium c h annel b lo c k e r s. 3) Diur e t ics Thiazide s an d congene r s. Loo p diur e tics. P o tassium-sparing diur e tics 4) Angio t ensin inhibi t o r s and antagonist s . Angi o t ensi n Co n v e r ting Enzyme ( A CE) inhibi t o r s. Angi o t ensi n recep t or antagonists.
Sympatholytic drugs The mechanism of action of these drug is caused by stimulation of α 2-adrenoreceptors in the inhibitory structure of the brain. Interaction of these drug with α 2-adrenergic receptors is expressed in the suppression of vasomotor centre neurons of the medulla and reduction of hypothalamus activity, which leads to a decline in sympathetic impulses to the vessels and the heart. In the result cardiac output and heart rate are moderately reduced and arterial pressure is reduced.